Capital Markets & Growth Firm supporting emerging tech. Enquiries & Portfolio below:
Toronto, Ontario
Joined April 2022
- Tweets4.9K
- Following1K
- Followers7.4K
- Likes7.5K
Microsoft targets 40% more AI output per megawatt. Circle plans to enter 40 markets. AstraZeneca commits $40M upfront to AI drug discovery.
This week’s Market Signals: where scale meets economics ↓
$42B in AI infrastructure financing. Tokenized US equities moving toward 24/7 trading. AI software starting to share revenue based on results.
This week’s Market Signals follows how the business models around emerging tech are changing ↓
$42B in AI infrastructure financing. Tokenized US equities moving toward 24/7 trading. AI software starting to share revenue based on results.
This week’s Market Signals follows how the business models around emerging tech are changing ↓
Follow the capital: $350M into specialized AI data, Binance deeper into USDC, and AI biotech heading to public markets.
This week’s Market Signals looks at where emerging tech is finding real commercial depth ↓
AI’s next bottleneck is connectivity. Europe is bringing central-bank settlement to tokenized markets. AI biotech is moving into the lab.
In Toronto this week? Join MCA’s Emerging Tech Room on Sept 24: luma.com/zbhm5t4z View article
AI infrastructure is expanding beyond chips.
Nasdaq is taking tokenized equities deeper into regulated markets.
Biotech is finding new value alongside existing treatments.
This week’s Market Signals ↓
AI data centers are being forced to prove demand. Tokenized equities are moving onto regulated exchanges. AI drug discovery is becoming a data race.
This week’s Market Signals looks at where infrastructure is becoming the real advantage ↓
AI is moving deeper into vertical workflows. Central banks are drawing clearer lines around digital money. Biotech is hitting manufacturing limits.
This week’s Market Signals looks at what happens when emerging tech reaches production ↓
